Online Launch Event for 'Clinical Trials Made Easy': Register for the Live Stream and Receive a Free Copy!

Ph.D. in Medicine and Engineering; Chief Pharmacist/Professor; Director of the Drug Clinical Trial Center and Phase I Clinical Research Unit, Director of the Center for Clinical Pharmacy, and Director of the New Drug Evaluation Department at the National Clinical Research Center for Kidney Diseases, Nanfang Hospital, Southern Medical University; Director of the Guangzhou-Hong Kong Collaborative Center for New Drug Clinical Research. Adjunct Professor and Graduate Supervisor at Jinan University and Guangzhou Medical University. Former Visiting Scholar at the Center for Clinical and Translational Sciences, Vanderbilt University (USA), and Former Visiting Professor at City of Hope National Medical Center (USA).

Major Academic Appointments:

Chairman of the Professional Committee on Clinical Evaluation of Drugs, Chinese Pharmaceutical Association;Vice Chairman of the Ethics Committee, Chinese Research Hospital Association;Deputy Director of the Key Laboratory for Drug Metabolism Research and Evaluation, National Medical Products Administration;Vice Chair of the Medical Ethics Branch, Guangdong Hospital Association;Standing Committee Member of the Ethics Branch, Guangdong Medical Association;Member of the Ethics Expert Committee of the Guangdong Provincial Health Commission;Executive Member of the Editorial Board and Deputy Director of the Editorial Office of Chinese Journal of Clinical Pharmacology, Chinese Pharmaceutical Association.

Founder of the High-Level Forum on Enhancing Clinical Research Capabilities and Protecting Subjects in China (CCHRPP); Lead of the Guangdong-Hong Kong-Macao Joint Platform for Shared Phase I & Bioequivalence Clinical Studies. Engaged in clinical pharmacokinetics/pharmacodynamics, therapeutic drug monitoring, and early-phase clinical trials; served as Principal Investigator for 50 Phase I clinical trials of Class 1.1 novel drugs. Secured more than 10 national and provincial/ministerial research grants. Recipient of five Military and Provincial Science and Technology Progress Awards; holder of over 30 patents and two software copyrights; author of more than 80 peer-reviewed publications. Honored with the “Most Beautiful Scientific and Technological Worker” title by the Chinese Pharmaceutical Association.

Ph.D., Chief Pharmacist, Master's Supervisor,Deputy Director of the Clinical Trial Center, Director of the Office, and Director of the Phase I Clinical Research Center at the Affiliated Hospital of Qingdao University;NMPA GCP Inspector;Standing Committee Member of the Professional Committee on Drug Clinical Trials, Chinese Pharmacological Society;Member of the Professional Committee on Clinical Evaluation of Drugs, Chinese Pharmaceutical Association;Deputy Head of the Early-Phase Clinical Trial Research Collaboration Group, Committee on Integrative Traditional Chinese and Western Medicine Oncology, China Anti-Cancer Association

With 18 years of experience in the management and execution of clinical trials, having overseen more than 600 clinical research projects;• Led over 160 BE/Phase I clinical trial projects;Editorial Board Member of the Chinese Journal of Clinical Pharmacology; Peer Reviewer for Chinese Hospital Pharmacy, Chinese Journal of New Drugs, and Chinese Journal of Drug Regulation; Peer Reviewer for Biomedicine & Pharmacotherapy and the Journal of Clinical Pharmacy and Therapeutics;Responsible for two research projects under the GCP platform of the National Major Science and Technology Projects;Published over 20 papers indexed by SCI.

Vice President of Medicine, Starnovo Biopharmaceutical Technology (Suzhou) Co., Ltd.;Researcher at the Center for Evidence-Based and Translational Medicine, Wuhan University;Member of the Academic Committee, Department of Clinical Epidemiology and Clinical Trials, Capital Medical University.

With 24 years of experience in clinical research, including seven years in the United States and Canada, and three years in Hong Kong and Singapore. Previously held positions such as Senior Director and Director at companies including PPD, ICON, Parexel, Xi’an Janssen, and BeiGene. Founding figure in China for Parkway Shenton, Tigermed, and Simico. Expertise in clinical study protocol design, project management and monitoring, auditing, data management, and statistical analysis. Experience spans Phase I, II, and III clinical trials, post-marketing clinical studies, real-world evidence studies, and investigator-initiated trials. Columnist for Pharmaceutical Economic News and Tongxieyi, with over 200 articles published on clinical research, as well as multiple articles in journals such as the Chinese Journal of New Drugs.

Peking University Guanghua EMBA,Chairman and General Manager of Beijing Caidesheng Pharmaceutical Technology Co., Ltd.;Director of the China Association for Pharmaceutical Quality Management;Member of the Professional Committee on Clinical Drug Evaluation Research, Jiangsu Pharmaceutical Association;Website Director for Drug Clinical Trials;Founder of WeTrial;Founder of Crlink (Clinical Trial Internet Service Platform);Standing Committee Member of the Youth Committee on Innovative Technology Research in Clinical Drug Trials.

Nearly 20 years of experience in clinical trial execution, operations, and management.Specializing in the development of innovative business operation models and strategic management for clinical trial services, and dedicated to the product design of internet-based clinical trial platforms and the exploration of digital transformation in clinical trial services.